Dopamine Transporter Genetic Reduction Induces Morpho-Functional Changes in the Enteric Nervous System

Antidopaminergic gastrointestinal prokinetics are indeed commonly used to treat gastrointestinal motility disorders, although the precise role of dopaminergic transmission in the gut is still unclear. Since dopamine transporter (DAT) is involved in several brain disorders by modulating extracellular...

Descripción completa

Detalles Bibliográficos
Autores principales: Cerantola, Silvia, Caputi, Valentina, Contarini, Gabriella, Mereu, Maddalena, Bertazzo, Antonella, Bosi, Annalisa, Banfi, Davide, Mantini, Dante, Giaroni, Cristina, Giron, Maria Cecilia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8146213/
https://www.ncbi.nlm.nih.gov/pubmed/33923250
http://dx.doi.org/10.3390/biomedicines9050465

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8146213/
https://www.ncbi.nlm.nih.gov/pubmed/33923250
http://dx.doi.org/10.3390/biomedicines9050465

Ejemplares similares